A Phase 1, Single‐center, Randomized, Open‐label, 2‐period, 2‐sequence Crossover study to evaluate the effect of a high‐fat meal on the pharmacokinetics single of oral dose of Brigatinib in Healthy subjects
Latest Information Update: 06 Feb 2019
At a glance
- Drugs Brigatinib (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
Most Recent Events
- 06 Feb 2019 New trial record